- Research works
- 76 ▲ 66% vs 2013–17
- Citations
- 3.6k 47.3 per fractional work
- Top-10% rate
- 37.0% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Biomarker Technologies (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.9×. Every wedge is a field page.
- Immunology and Microbiology 6.9×
- Biochemistry, Genetics and Molecular Biology 4.5×
- Energy 3.1×
- Neuroscience 2.1×
- Medicine 1.8×
- Agricultural and Biological Sciences 1.7×
- Earth and Planetary Sciences 1.6×
- Nursing 1.3×
- Engineering 0.7×
- Environmental Science 0.7×
- Dentistry 0.4×
- Business, Management and Accounting 0.3×
- Materials Science 0.2×
- Chemistry 0.2×
- Health Professions 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
Which keywords describe research at Biomarker Technologies (China)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, Genetic Diversity, RNA-Seq, Phylogenetic Analysis, Inflammation, Quality Assessment, Functional Genomics and QTL Mapping.
- Small RNAs
- Asthma
- Glycosylation
- Anthocyanins
- Shale Gas
- Molecular Markers
- Genomic Instability
- Epigenetic Regulation
- Domestication
- PD-1 and PD-L1
- Neurodegeneration
- Genomics
- Genome Sequencing
- Targeted Therapy
- genome annotation
- Genetics
- Functional Genomics
- Phylogenetic Analysis
- Oxidative Stress
- Inflammation
- Gene Expression
- Genetic Diversity
- RNA-Seq
- Quality Assessment
- QTL Mapping
- Tumor Microenvironment
- sequence alignment
- Genetic Mapping
- Data Analysis
- Mitochondrial Dysfunction
- Immune Checkpoint Blockade
- Quantitative Trait Loci
- Drought Tolerance
- Cancer Genomics
- Mass Spectrometry
- Mutational Signatures
- Transcription Factors
- Cancer Immunotherapy
- Normalization
- Pathogenicity
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Expression5▲ 10×11 topics
- Inflammation5▲ 2.7×31 topics
- Genetic Diversity4▲ 11×10 topics
- Oxidative Stress4▲ 2.7×24 topics
- RNA-Seq4▲ 52×2 topics
- Phylogenetic Analysis3▲ 11×6 topics
- Quality Assessment3▲ 19×2 topics
- Functional Genomics3▲ 38×2 topics
- QTL Mapping3▲ 30×6 topics
- Genetics2▲ 4.3×8 topics
- Tumor Microenvironment2▲ 9.2×4 topics
- genome annotation2▲ 45×1 topic
- sequence alignment2▲ 45×1 topic
- Targeted Therapy2▲ 14×5 topics
- Genetic Mapping2▲ 26×5 topics
- Genome Sequencing2▲ 15×6 topics
- Data Analysis2▲ 7.5×3 topics
- Genomics2▲ 7.1×7 topics
- Mitochondrial Dysfunction2▲ 6.8×6 topics
- Neurodegeneration2▲ 8.1×7 topics
- Immune Checkpoint Blockade2▲ 42×1 topic
- PD-1 and PD-L12▲ 42×1 topic
- Quantitative Trait Loci2▲ 32×3 topics
- Domestication2▲ 43×3 topics
- Drought Tolerance2▲ 16×5 topics
- Epigenetic Regulation2▲ 10×4 topics
- Cancer Genomics2▲ 36×1 topic
- Genomic Instability2▲ 16×2 topics
- Mass Spectrometry2▲ 9.2×4 topics
- Molecular Markers2▲ 38×2 topics
- Mutational Signatures2▲ 36×1 topic
- Shale Gas2▲ 15×2 topics
- Transcription Factors2▲ 14×2 topics
- Anthocyanins1▲ 30×2 topics
- Cancer Immunotherapy1▲ 13×2 topics
- Glycosylation1▲ 8.3×3 topics
- Normalization1▲ 25×2 topics
- Asthma1▲ 14×3 topics
- Pathogenicity1▲ 19×3 topics
- Small RNAs1▲ 21×2 topics
Which research topics does Biomarker Technologies (China) publish most on?
By volume in 2022–2025: Reservoir Engineering and Simulation Methods, Genomics and Phylogenetic Studies, Oil, Gas, and Environmental Issues and Gut microbiota and health.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Reservoir Engineering and Simulation Methods Ocean Engineering 1 works
- 2 Genomics and Phylogenetic Studies Molecular Biology 1 works
- 3 Oil, Gas, and Environmental Issues Renewable Energy, Sustainability and the Environment 0 works
- 4 Gut microbiota and health Molecular Biology 0 works
- 5 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 7 T-cell and B-cell Immunology Immunology 0 works
- 8 3D Printing in Biomedical Research Biomedical Engineering 0 works
- 9 Nanotechnology research and applications Biomedical Engineering 0 works
- 10 Single-cell and spatial transcriptomics Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biomarker Technologies (China)'s research output changed?
Output in 2018–2022 was 66% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.